|
GSK2636771
- 英文名称：GSK2636771
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11140
- cas：1372540-25-4
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11140 |
| 用途 | 科研检测 |
| 英文名称 | GSK2636771 |
| 包装规格 | 1MG |
| CAS编号 | 1372540-25-4 |
| 别名 | GSK2636771 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C22H22F3N3O3
分子量:433.43
溶剂:DMSO (20 mg/ml)
性状:Pale yellow solid
存储:-20°C
Activity (short version):Selective PI3K? inhibitor
Function / Pharmacology:GSK2636771 is a potent, selective (>1000-fold over α, 10-fold over δ, and >2000-fold over γ), and orally bioavailable inhibitor of PI3K? (IC50 = 5.2 nM).1 Active in vitro against multiple types of PTEN-deficient cancer cells. GSK2636771 potently blocked migration and invasion of DU145 prostate cancer cells.2 GSK2636771 has also been identified as a GPR39 agonist.3
分子式:C22H22F3N3O3
分子量:433.43
溶剂:DMSO (20 mg/ml)
性状:Pale yellow solid
存储:-20°C
Activity (short version):Selective PI3K? inhibitor
Function / Pharmacology:GSK2636771 is a potent, selective (>1000-fold over α, 10-fold over δ, and >2000-fold over γ), and orally bioavailable inhibitor of PI3K? (IC50 = 5.2 nM).1 Active in vitro against multiple types of PTEN-deficient cancer cells. GSK2636771 potently blocked migration and invasion of DU145 prostate cancer cells.2 GSK2636771 has also been identified as a GPR39 agonist.3
